-+ 0.00%
-+ 0.00%
-+ 0.00%

CERENOME - NO DOSE-LIMITING TOXICITIES OR ADVERSE EVENTS LEADING TO DISCONTINUATION REPORTED

Reuters·11/16/2026 12:32:57